Because of the need for more effective treatments in HHT and the involvement of ENG in angiogenesis, current studies are aimed at identifying novel biological functions of ENG which could serve as a therapeutic target. This evidence concerns the gene ENG and hereditary hemorrhagic telangiectasia.